Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 7, pp. 4514-4540
Open Access | Times Cited: 132

Showing 26-50 of 132 citing articles:

Synthesis, Intramolecular Cyclization, and Anti-inflammatory Activity of Substituted 2-[2-(4-R-Benzoyl)hydrazinylidene]-4-oxobutanoic Acids
D. V. Lipin, E. I. Denisova, D. A. Shipilovskikh, et al.
Russian Journal of Organic Chemistry (2022) Vol. 58, Iss. 12, pp. 1759-1768
Closed Access | Times Cited: 22
Emerging drug design strategies in anti-influenza drug discovery
Chuanfeng Liu, Lide Hu, Guanyu Dong, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4715-4732
Open Access | Times Cited: 12
Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
Irene Arduino, Rachele Francese, Andrea Civra, et al.
Antiviral Research (2024) Vol. 226, pp. 105897-105897
Open Access | Times Cited: 4
Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer
Shuohui Dong, Mingguang Zhang, Zhiqiang Cheng, et al.
Redox Biology (2024) Vol. 73, pp. 103207-103207
Open Access | Times Cited: 4
Commercialization of endophytic fungus–derived therapeutics: Opportunities and challenges
Mukhtar Lawal Abubakar, Neha Kapoor, Asha Sharma, et al.
Elsevier eBooks (2025), pp. 233-250
Closed Access
Synthesis and Study of Antimicrobial Activity of Reaction Products of Substituted 3-Thienylimino-3H-furan-2-ones with Substituted Hydrazines and Hydrazides
D. V. Lipin, Н. А. Пулина, В. В. Новикова, et al.
Russian Journal of General Chemistry (2025) Vol. 95, Iss. 2, pp. 291-300
Closed Access
Ethnomedicinal, Phytochemistry and Antiviral Potential of Turmeric (Curcuma longa)
Bajarang Bal Lal Srivastava, Asha Ripanda, Hossein Miraji
Compounds (2022) Vol. 2, Iss. 3, pp. 200-221
Open Access | Times Cited: 21
Medicinal chemistry insights into antiviral peptidomimetics
Dang Ding, Shujing Xu, Edeildo Ferreira da Silva‐Júnior, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 3, pp. 103468-103468
Closed Access | Times Cited: 19
Synthesis, anti-inflammatory activity, and acute toxicity of the substituted 2-[2-(4-nitrobenzoyl)hydrazono]-4-oxobutanoates
D. V. Lipin, S. K. Metlyakova, D. A. Shipilovskikh, et al.
Russian Chemical Bulletin (2023) Vol. 72, Iss. 8, pp. 1887-1893
Closed Access | Times Cited: 11
Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
Yang Zhou, Shujing Xu, Nerea López-Carrobles, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 10
Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIs
Yanying Sun, Zhenzhen Zhou, Na Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6570-6584
Closed Access | Times Cited: 3
Emerging affinity methods for protein-drug interaction analysis
Xinxin Zheng, Huiting Zhu, Xue Zhao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 249, pp. 116371-116371
Closed Access | Times Cited: 3
Photosensitizing Antivirals
Kseniya A. Mariewskaya, Anton P. Tyurin, Alexey A. Chistov, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3971-3971
Open Access | Times Cited: 26
Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71
Guangyan Zhu, Chengyuan Wu, Qian Wang, et al.
Antiviral Research (2023) Vol. 211, pp. 105553-105553
Open Access | Times Cited: 9
Escaping from Flatland: Multiparameter Optimization Leads to the Discovery of Novel Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Human Immunodeficiency Virus-1 Non-nucleoside Reverse Transcriptase Inhibitors with Superior Antiviral Activities against Non-nucleoside Reverse Transcriptase Inhibitor-Resistant Variants and Favorable Drug-like Profiles
Zhao Wang, Prem P. Sharma, Brijesh Rathi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8643-8665
Closed Access | Times Cited: 9
Ring Opening of Substituted 3-[2-(4-Nitrobenzoyl)­hydrazinylidene]furan-2(3H)-ones with Primary Alcohols. Analgesic Activity and Acute Toxicity of the Products
D. V. Lipin, E. I. Denisova, D. A. Shipilovskikh, et al.
Russian Journal of Organic Chemistry (2023) Vol. 59, Iss. 4, pp. 631-638
Closed Access | Times Cited: 9
Design and synthesis of APN and 3CLpro dual‐target inhibitors based on STSBPT with anticoronavirus activity
Youle Zheng, Feng Jin, Yanbin Song, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 3
Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade
Mateus Sá Magalhães Serafim, Valtair Severino dos Santos, Jadson Castro Gertrudes, et al.
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 9, pp. 961-975
Closed Access | Times Cited: 22
Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic
Jacqueline A. Takahashi, Bianca Vianna Rodrigues Barbosa, Matheus Thomaz Nogueira Silva Lima, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116366-116366
Open Access | Times Cited: 21
Discovery of Novel Dihydrothiopyrano[4,3-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles
Zhao Wang, Waleed A. Zalloum, Wenbo Wang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13658-13675
Open Access | Times Cited: 20
Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti‐SARS‐CoV‐2 Activity
Bianca Schulte, Maria König, Beate I. Escher, et al.
ChemMedChem (2022) Vol. 17, Iss. 5
Open Access | Times Cited: 14
Micro-total process system machine (μ-TPSM) for rapid synthesis of antiretroviral darunavir
Ruchi Chauhan, Abhilash Rana, Subhash Ghosh, et al.
Reaction Chemistry & Engineering (2023) Vol. 8, Iss. 4, pp. 908-916
Closed Access | Times Cited: 8
Computational Studies of Selected Transition Metal Complexes as Potential Drug Candidates against the SARS‐CoV‐2 Virus
Maynak Pal, Dulal Musib, Aniket J. Zade, et al.
ChemistrySelect (2021) Vol. 6, Iss. 29, pp. 7429-7435
Open Access | Times Cited: 19
HIV-1 Capsid Inhibitors: A Sword to Destroy the Virus
Xujie Zhang, Shujing Xu, Lin Sun, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 9, pp. 605-607
Closed Access | Times Cited: 12
From design to biological mechanism evaluation of phenylalanine-bearing HIV-1 capsid inhibitors targeting a vital assembly interface
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 3, pp. 107611-107611
Closed Access | Times Cited: 12

Scroll to top